Mark W. Holladay
43Patents
15h-index
91Co-inventors
84Inventor score
Filing activity: Jun 17, 1991 → Jun 28, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5629325A | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission | Chemistry; Metallurgy | 60 | Expired |
| US5346907A | Amino acid analog CCK antagonists | Chemistry; Metallurgy | 51 | Expired |
| US5948793A | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release | Chemistry; Metallurgy | 36 | Expired |
| US8030488B2 | Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents | Chemistry; Metallurgy | 33 | Active |
| US5914328A | Heterocyclic ether compounds useful in controlling neurotransmitter release | Chemistry; Metallurgy | 32 | Expired |
| US7335658B2 | Pyridazine derivatives and their use as therapeutic agents | Chemistry; Metallurgy | 32 | Expired |
| US5340802A | Peptide analog type-B CCK receptor ligands | Human Necessities | 31 | Expired |
| US5472958A | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function | Human Necessities | 29 | Expired |
| US6127386A | 3-Pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission | Chemistry; Metallurgy | 27 | Expired |
| US6437138B1 | 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission | Chemistry; Metallurgy | 24 | Expired |
| US8618289B2 | RAF kinase modulator compounds and methods of use thereof | Chemistry; Metallurgy | 21 | Active |
| US7749980B2 | Non-nucleotide compositions and method for treating pain | Human Necessities | 19 | Active |
| US5733912A | 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission | Human Necessities | 18 | Expired |
| US6265417A | Potassium channel openers | Chemistry; Metallurgy | 16 | Expired |
| US7456180B2 | Piperazine derivatives and their use as therapeutic agents | Chemistry; Metallurgy | 15 | Expired |
| US5270302A | Derivatives of tetrapeptides as CCK agonists | Human Necessities | 14 | Expired |
| US6593335B1 | Potassium channel openers | Chemistry; Metallurgy | 14 | Expired |
| US7919484B2 | Combination therapy | Human Necessities | 9 | Active |
| US8969587B2 | RAF kinase modulator compounds and methods of use thereof | Chemistry; Metallurgy | 7 | Active |
| US6133253A | 3-Pyridyl enantiomers and their use as analgesics | Chemistry; Metallurgy | 7 | Expired |
| US9320739B2 | RAF kinase modulator compounds and methods of use thereof | Chemistry; Metallurgy | 6 | Active |
| US6001849A | Furopyridine, thienopyridine pyrrolopyridine useful in controlling chemical synaptic transmission | Chemistry; Metallurgy | 3 | Expired |
| US9725465B2 | Biaryl acetamide compounds and methods of use thereof | Chemistry; Metallurgy | 3 | Active |
| US6274587A | Tricyclic dihydropyrimidine potassium channel openers | Chemistry; Metallurgy | 3 | Expired |
| US10829484B2 | Compounds and methods for kinase modulation, and indications therefor | Chemistry; Metallurgy | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.